Sarepta Therapeutics (SRPT) PT Lowered to $150 at Oppenheimer

March 9, 2023 7:31 AM EST Send to a Friend

Oppenheimer analyst Hartaj Singh lowered ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Sarepta Therapeutics (SRPT) PT Lowered to $150 at Oppenheimer

Member Login

Free News Feed